Leucovorin

— THERAPEUTIC CATEGORIES —
  • Anemias
  • Colorectal and other GI cancers
  • Cytoprotective and supportive care agents

Leucovorin Generic Name & Formulations

General Description

Leucovorin calcium 100mg/vial, 350mg/vial; lyophilized pwd for IV or IM inj after reconstitution; preservative-free.

Pharmacological Class

Folic acid derivative.

How Supplied

Single-use vials—1

Manufacturer

Leucovorin Indications

Indications

Megalobastic anemia due to folic acid deficiency when oral therapy is not feasible.

Leucovorin Dosage and Administration

Adult

Up to 1mg daily.

Children

See literature.

Leucovorin Contraindications

Contraindications

Pernicious anemia and other megaloblastic anemias due to Vit. B12 deficiency.

Leucovorin Boxed Warnings

Not Applicable

Leucovorin Warnings/Precautions

Warnings/Precautions

Do not administer intrathecally. CNS metastases. Monitor CBCs with differential, platelets, electrolytes, liver function tests prior to each treatment, then periodically. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers.

Leucovorin Pharmacokinetics

See Literature

Leucovorin Interactions

Interactions

Potentiates toxicity of 5-fluorouracil; use lower 5-fluorouracil dose. May antagonize phenobarbital, phenytoin, and primidone. Caution with trimethoprim-sulfamethoxazole.

Leucovorin Adverse Reactions

Adverse Reactions

Leukopenia, thrombocytopenia, infection, GI upset, stomatitis, constipation, lethargy, malaise, fatigue, alopecia, dermatitis, anorexia; seizures, syncope.

Leucovorin Clinical Trials

See Literature

Leucovorin Note

Not Applicable

Leucovorin Patient Counseling

See Literature

Leucovorin Generic Name & Formulations

General Description

Leucovorin calcium 100mg/vial, 350mg/vial; lyophilized pwd for IV or IM inj after reconstitution; preservative-free.

Pharmacological Class

Folic acid derivative.

How Supplied

Single-use vials—1

Manufacturer

Leucovorin Indications

Indications

Palliative treatment of advanced colorectal cancer in combination with 5-fluorouracil.

Leucovorin Dosage and Administration

Adult

Max IV infusion rate: 160mg/min. 200mg/m2 by slow IV inj over a minimum of 3 minutes, followed by 5-fluorouracil (370mg/m2); or 20mg/m2 IV followed by 5-fluorouracil (425mg/m2); both regimens: daily for 5 days, may be repeated at 4-week intervals for 2 courses and then repeated at 4–5 week intervals (if completely recovered from toxic effects of previous course).

Children

See literature.

Leucovorin Contraindications

Contraindications

Pernicious anemia and other megaloblastic anemias due to Vit. B12 deficiency.

Leucovorin Boxed Warnings

Not Applicable

Leucovorin Warnings/Precautions

Warnings/Precautions

Do not administer intrathecally. CNS metastases. Monitor CBCs with differential, platelets, electrolytes, liver function tests prior to each treatment, then periodically. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers.

Leucovorin Pharmacokinetics

See Literature

Leucovorin Interactions

Interactions

Potentiates toxicity of 5-fluorouracil; use lower 5-fluorouracil dose. May antagonize phenobarbital, phenytoin, and primidone. Caution with trimethoprim-sulfamethoxazole.

Leucovorin Adverse Reactions

Adverse Reactions

Leukopenia, thrombocytopenia, infection, GI upset, stomatitis, constipation, lethargy, malaise, fatigue, alopecia, dermatitis, anorexia; seizures, syncope.

Leucovorin Clinical Trials

See Literature

Leucovorin Note

Not Applicable

Leucovorin Patient Counseling

See Literature

Leucovorin Generic Name & Formulations

General Description

Leucovorin calcium 100mg/vial, 350mg/vial; lyophilized pwd for IV or IM inj after reconstitution; preservative-free.

Pharmacological Class

Folic acid derivative.

How Supplied

Single-use vials—1

Manufacturer

Leucovorin Indications

Indications

Rescue treatment after high-dose methotrexate therapy in osteosarcoma.

Leucovorin Dosage and Administration

Adult

Max IV infusion rate: 160mg/min. Based on methotrexate dose. Normal methotrexate elimination: 15mg IM or IV every 6 hours for 10 doses starting 24 hours after the beginning of the methotrexate infusion. Delayed late or delayed early methotrexate elimination, and/or evidence of acute renal injury, impaired methotrexate elimination or inadvertent overdosage: see literature.

Children

See literature.

Leucovorin Contraindications

Contraindications

Pernicious anemia and other megaloblastic anemias due to Vit. B12 deficiency.

Leucovorin Boxed Warnings

Not Applicable

Leucovorin Warnings/Precautions

Warnings/Precautions

Do not administer intrathecally. Monitor serum methotrexate concentration. CNS metastases. Monitor CBCs with differential, platelets, electrolytes, liver function tests prior to each treatment, then periodically. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers.

Leucovorin Pharmacokinetics

See Literature

Leucovorin Interactions

Interactions

Potentiates toxicity of 5-fluorouracil; use lower 5-fluorouracil dose. May antagonize phenobarbital, phenytoin, and primidone. Caution with trimethoprim-sulfamethoxazole.

Leucovorin Adverse Reactions

Adverse Reactions

Leukopenia, thrombocytopenia, infection, GI upset, stomatitis, constipation, lethargy, malaise, fatigue, alopecia, dermatitis, anorexia; seizures, syncope.

Leucovorin Clinical Trials

See Literature

Leucovorin Note

Not Applicable

Leucovorin Patient Counseling

See Literature